Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Buying $1000 In MASI: If an investor had bought $1000 of MASI stock 10 years ago, it would be worth $5,655.84 today based on a price of $144.22 for MASI at the time of writing.

The consensus rating for Masimo is Buy, based on 2 analyst ratings. With an average one-year price target of $167.5, there's a potential 16.14% upside.

In its upcoming report, Masimo (MASI) is predicted by Wall Street analysts to post quarterly earnings of $0.84 per share, reflecting an increase of 33.3% compared to the same period last year.

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

Masimo backs FY24 EPS view $3.80-$4.00, consensus $3.88 Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo (MASI) adopted ...

Medical-device maker said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been ...

Apple wins $250 from Masimo in its smartwatch patent infringement case, but the victory doesn’t change much in its larger ...

Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...